Interested in the Pfizer-BioNTech COVID 19 Vaccine?

This page contains information for the Pfizer-BioNTech COVID-19 vaccine.

Please check in frequently as information will be posted as it becomes availible.

Resources and Information for for Pzizer-BioNTech Vaccine

FDA Fact Sheet Pfizer-BioNTech COVID-19 Vaccine Recipients - updated 12/24/2020

FDA Fact Sheet Pfizer-BioNTech COVID-19 for Healthcare Providers Administering Vaccine - updated 12/24/2020

MMWR: The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine — United States, December 2020 - posted 12/13/2020

What Clinicians Need to Know About the Pfizer-BioNTech COVID-19 Vaccine - posted 12/13/2020

CDC Pfizer-BioNTech Standing Orders - posted 12/16/2020

CDC Pfizer-BioNTech Vaccine Preparation Information - posted 12/16/2020

CDC Pfizer-BioNTech COVID 19 Pre-Vaccination Form- posted 12/16/20

Pfizer EUA letter of authorization - posted 12/24/2020

FDA Pfizer-BioNTech EUA Information - posted 12/18/2020

NEW Product Information Guide for COVID-19 Vaccines and Associated Products - posted 1/20/2021

Vaccinating Persons with History of Allergies

CDC has issued an MMWR on anaphylaxis reactions for the Pfizer-BioNtech vaccine. 21 cases of anaphylaxis are reported of a total of 1,893,360 vaccine doses administered. 17 of these 21 had a history of allergies or allergic reaction and 7 of these had a history of anaphylaxis. 71% of reported anaphylaxis episodes occurred within the first 15 minutes of vaccination. Read the full report here.

 

Find full considerations from CDC here including detailed updated information on clinical considerations. Guidelines were updated by CDC on 3/5/21 - including clarifications on contraindications and precautions.

Announcements

As of April 19, all Chicagoans age 16 and up are eligible for vaccination in Chicago (phase 2).

 

The Johnson & Johnson COVID-19 vaccine was officially granted Emergency Use Authorization (EUA) by the FDA on February 27, 2021 and recommended by the CDC Advisory Committee on Immunization Practices (ACIP) on February 28, 2021. Find J&J specific materials linked above.

NEW:  Product Information Guide (v7 issued March 2, 2021)

NEW:  Ancillary kit syringe and needle deficiency reporting

NEW COVID-19 Vaccine Provider Videos 

Race/Ethnicity Reporting Updates (2/16/21)

Quick Provider Ordering Tips (2/16/21)

VaccineFinder Inventory Reporting in 3 Easy Steps (2/16/21)

Instructions on signing up for ZocDoc (2/8/2021)

CDPH has compiled a provider toolkit which can be used to engage patients and employees eligible for vaccine. Find here under the "toolkits" tab.

NEW  CDPH Provider Update - issued Jan 28, 2021

CDC has issued an MMWR on anaphylaxis reactions for the Pfizer-BioNtech vaccine. 21 cases of anaphylaxis are reported of a total of 1,893,360 vaccine doses administered. 17 of these 21 had a history of allergies or allergic reaction and 7 of these had a history of anaphylaxis. 71% of reported anaphylaxis episodes occurred within the first 15 minutes of vaccination. Read the full report here.

 

Covid-19 Vaccination Chicago Provider Letter from CDPH - posted 12/18/2020

See the CDC site for updated reporting on total administered vaccine doses in the USA.

COVID-19 Vaccine Contact Information

 

Please direct all questions to COVID19vaccine@cityofchicago.org.

 

Please visit the Illinois Department of Public Health I-CARE website for information on enrolling a facility or individual in I-CARE: https://www.dph.illinois.gov/topics-services/prevention-wellness/immunization/icare

 

For information on the vaccine please go to: www.chicago.gov/covidvax.

Storage and Handling

The following resources are available to assist providers in storing and handling of the Pfizer-BioNTech COVID-19 vaccine.

Dry Ice Saftey Healthcare
Pfizer BUD Tracking Labels
Pfizer Storage Label
Pfizer Storage Summary
Pfizer TempLog ULTRACOLDStorage Celsius
Pfizer TempLog ULTRACOLDStorage Fahrenheit
Vaccine Expiration Date Tracker